Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pratico

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Stem Cells and Development|July 16, 2015
RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit(+) Cardiac Progenitor CellsElizabeth D Pratico, Bryan J Feger, Michael J Watson, et al.
Journal of Internal Medicine|November 21, 2008
Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosisN Mattsson, M Yaong, L Rosengren, et al.
Plos One|April 17, 2014
Targeted disruption of β-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growthJonathan W Kotula, Jinpeng Sun, Margie Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2012
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progressionC E Teunissen, M Sombekke, L van Winsen, et al.
Circulation|June 3, 1997
8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivoN Delanty, M P Reilly, D Pratico, et al.
Journal of Internal Medicine|August 25, 2004
MRI and CSF studies in the early diagnosis of Alzheimer's diseaseM J de Leon, S DeSanti, R Zinkowski, et al.
Journal of Neurology|November 13, 2007
Longitudinal CSF isoprostane and MRI atrophy in the progression to ADM J de Leon, L Mosconi, J Li, et al.
Annals of the New York Academy of Sciences|April 7, 2007
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's diseaseM J de Leon, L Mosconi, K Blennow, et al.
Neurology|May 30, 2008
Biochemical markers in persons with preclinical familial Alzheimer diseaseJ M Ringman, S G Younkin, D Pratico, et al.
Current Drug Safety|June 21, 2018
Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter StudyAndrea D Pratico, Laura Longo, Silvana Mansueto, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Stem Cells and Development|July 16, 2015
RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit(+) Cardiac Progenitor CellsElizabeth D Pratico, Bryan J Feger, Michael J Watson, et al.
Journal of Internal Medicine|November 21, 2008
Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosisN Mattsson, M Yaong, L Rosengren, et al.
Plos One|April 17, 2014
Targeted disruption of β-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growthJonathan W Kotula, Jinpeng Sun, Margie Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2012
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progressionC E Teunissen, M Sombekke, L van Winsen, et al.
Circulation|June 3, 1997
8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivoN Delanty, M P Reilly, D Pratico, et al.
Journal of Internal Medicine|August 25, 2004
MRI and CSF studies in the early diagnosis of Alzheimer's diseaseM J de Leon, S DeSanti, R Zinkowski, et al.
Journal of Neurology|November 13, 2007
Longitudinal CSF isoprostane and MRI atrophy in the progression to ADM J de Leon, L Mosconi, J Li, et al.
Annals of the New York Academy of Sciences|April 7, 2007
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's diseaseM J de Leon, L Mosconi, K Blennow, et al.
Neurology|May 30, 2008
Biochemical markers in persons with preclinical familial Alzheimer diseaseJ M Ringman, S G Younkin, D Pratico, et al.
Current Drug Safety|June 21, 2018
Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter StudyAndrea D Pratico, Laura Longo, Silvana Mansueto, et al.
Pageof 4